Wnt proteins and their receptors, members of the frizzled protein family, play a key role in regulating a wide range of developmental processes. Recently, putative regulators of Wnt signaling known as secreted frizzled-related proteins (SFRPs) have been identified in several vertebrates. Here, we describe the cloning of a novel SFRP (suSFRP1) from the sea urchin, Strongylocentrotus purpuratus. SuSFRP1 contains a putative signal sequence, four cysteine-rich domains and a single Ig domain. The developmental expression of suSFRP1 mRNA is highly dynamic and can be separated into three phases: (1) abrupt accumulation in most or all cells of the embryo at the early blastula stage; (2) restriction of expression to the prospective endoderm and animal pole region of the gastrula; and (3) expression in prospective muscle cells of the coelomic pouches during late embryogenesis. q
Results
The secreted frizzled-related proteins (SFRPs) that have been described are small (,30 kDa) proteins consisting of a signal sequence and a single cysteine-rich domain (CRD) (Finch et al., 1997; Leyns et al., 1997; Rattner et al., 1997; Salic et al., 1997; Wang et al., 1997; Xu et al., 1998; Chang et al., 1999) . The CRD is a motif of ,120 amino acids with a highly conserved spacing of ten cysteine residues. A CRD is present in the extracellular region of frizzled receptors and this motif is also found in several other proteins (see Roszmusz et al., 2001) . The CRDs of frizzled receptors and SFRPs have highly similar structures and both can bind Wnt proteins Uren et al., 2000; Dann et al., 2001) . Sequestering of Wnts has been postulated to account for the antagonistic effects of SFRPs on Wnt signaling (Finch et al., 1997; Leyns et al., 1997; Lin et al., 1997; Wang et al., 1997; Bafico et al., 1999; Hsieh et al., 1999) .
In a large-scale, sea urchin embryo cDNA sequencing project (Zhu et al., 2001 ), we identified a clone (PC_0013_A1_C05) that encoded a member of the SFRP family (suSFRP1). The clone appeared to include the entire open reading frame and 3 0 -UTR of the mRNA. It contained only 33 nt of 5 0 -UTR upstream of a putative start methionine, however, and lacked upstream stop codons. A probe complementary to the 5 0 end of PC_0013_A1_C05 (Fig. 1, probe suSFRP-EcoR1.SacII) was used to screen two highdensity filters (,36,000 clones total) from an arrayed cDNA library generated from 20 h Strongylocentrotus purpuratus embryos (Rast et al., 2000) . Fifteen positive clones were identified, and polymerase chain reaction (PCR) analysis showed that all 15 contained short 5 0 -UTRs similar in length to the original clone. The longest 5 0 sequence (clone 50-L4) contained an additional 59 nt upstream that included two inframe stop codons. and probes used for library screening and in situ hybridization. Clone suSFRP-EcoR1.SacII was used to generate a probe for cDNA library screening. Probes for in situ hybridization were generated from suSFRP1-FL and suSFRP-PstI. The latter was used to avoid possible cross-hybridization with other sea urchin sequences containing CRDs.
The domain organization and complete sequence of suSFRP1 are shown in Figs. 1 and 2. The putative N-terminal methionine is followed by a signal sequence, with a predicted cleavage site between residues 23 and 24 (Nielsen et al., 1997) . The presence of a signal sequence suggests that suSFRP1 is a secreted protein. Most of the coding region of suSFRP1 consists of four well-conserved CRD domains (Fig. 3 ). An Ig domain is located between CRD3 and CRD4. SuSFRP1 does not contain a transmembrane domain or the Lys-Thr-X-X-X-Trp motif required by frizzled receptors for signaling (Umbhauer et al., 2000) . Northern blotting identified a single major ,3.6 kb transcript (Fig. 4) , a size that corresponded well to the predicted length of the suSFRP1 mRNA. The transcript was not detectable in unfertilized eggs or cleavage stage embryos but was expressed at high levels by the blastula stage. Levels of suSFRP1 mRNA declined progressively during later development, although the transcript continued to be expressed at detectable levels as late as the pluteus larva stage.
In situ hybridization studies were carried out using two RNA probes (Fig. 1 , probes suSFRP-FL and suSFRP-PstI) that yielded identical results (Fig. 5) . suSFRP1 mRNA was not detectable in eggs or early cleavage stage embryos. Transcript accumulated to high levels in most or all cells by the early blastula stage. At the late blastula stage, a region in the center of the vegetal plate that lacked suSFRP mRNA was apparent. This is the location of the presumptive primary mesenchyme cells (PMCs), and PMCs did not show detectable levels of expression after ingression (Fig. 5) . At the mesenchyme blastula stage, levels of suSFRP1 mRNA declined markedly throughout much of the embryo. Prominent zones of expression were evident, however, in presumptive endoderm at the rim of the blastopore and in ectoderm at the animal pole. This pattern of expression persisted throughout gastrulation, although the level of suSFRP1 mRNA gradually declined. By the end of gastrulation, a pronounced increase in expression was evident in the presumptive coelomic pouches, two bilateral outpocketings of mesodermal cells near the tip of the archenteron. Expression was restricted to a group of cells at the base of each coelomic pouch, a region that will give rise to circumesophageal muscle cells (Ettensohn and Ruffins, 1993) . The pattern of suSFRP1 mRNA expression is summarized in Fig. 6 .
Methods
Screening of high-density cDNA library filters was performed according to Rast et al. (2000) . Northern blotting was carried out following the protocol of the Northern Max kit (Ambion). In both cases, digoxigenin-labeled RNA probes were used and hybridization signal was detected using a Digoxigenin Luminescent Detection kit (Roche). Whole mount in situ hybridizations were performed as described in Zhu et al. (2001) . Fig. 6 . A summary of suSFRP1 mRNA expression based on whole mount in situ hybridization analysis. SuSFRP1 shows a dynamic pattern of expression that can be divided into three major phases: (1) activation in most or all cells of the early blastula; (2) restriction of expression to the prospective endoderm and animal pole region of the gastrula; and (3) expression in prospective muscle cells of the coelomic pouches during late embryogenesis, concomitant with down-regulation of the gene in the remainder of the embryo.
